Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis.

Solèr M, Lode H, Baldwin R, Levine JH, Schreurs AJ, van Noord JA, Maesen FP, Zehrer M; European Gatifloxacin Study group.

Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):144-50. Epub 2003 Mar 5.

PMID:
12649711
3.

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.

Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.

J Antimicrob Chemother. 1999 Apr;43(4):529-39.

PMID:
10350383
4.
6.

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action.

van Noord JA, Smeets JJ, Raaijmakers JA, Bommer AM, Maesen FP.

Eur Respir J. 1996 Aug;9(8):1684-8.

7.

Onset of action of eformoterol by dry powder inhaler: objective and subjective measures.

Maesen FP, Smeets SJ, Costongs MA, Zweers PG, Pfeil JP.

Br J Clin Pract. 1995 Nov-Dec;49(6):294-6.

PMID:
8554951
9.

Eformoterol versus salbutamol in patients with ROAD.

Maesen FP.

Br J Clin Pract Suppl. 1995 Sep;81:8-10. No abstract available.

PMID:
8546895
10.

Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.

Rutten-van Mölken MP, Custers F, van Doorslaer EK, Jansen CC, Heurman L, Maesen FP, Smeets JJ, Bommer AM, Raaijmakers JA.

Eur Respir J. 1995 Jun;8(6):888-98.

11.

Evaluation of different doses of formoterol from a newly developed powder inhalation device in asthmatic patients.

van den Berg BT, Smeets JJ, van Boxtel CJ, Maesen FP.

Fundam Clin Pharmacol. 1995;9(6):593-603.

PMID:
8808181
12.

Effect of zatebradine, a novel 'sinus node inhibitor', on pulmonary function compared to placebo.

Maesen FP, Smeets JJ, van Noord JA, Nehmiz G, Wald FD, Cornelissen PJ.

Pulm Pharmacol. 1994 Dec;7(6):349-55.

PMID:
7549222
13.

Lipoma of the external thoracic wall.

Sulzer MA, Goei R, Bollen EC, Theunissen PH, Maesen FP.

Eur Respir J. 1994 Jan;7(1):207-9.

14.

Ba 679 Br, a new long-acting antimuscarinic bronchodilator: a pilot dose-escalation study in COPD.

Maesen FP, Smeets JJ, Costongs MA, Wald FD, Cornelissen PJ.

Eur Respir J. 1993 Jul;6(7):1031-6.

PMID:
8370429
15.

[Greater deterioration of lung function in COPD during continuous than during symptom-oriented bronchodilator treatment].

Maesen BL, Maesen FP.

Ned Tijdschr Geneeskd. 1993 Jun 5;137(23):1158-60. Dutch. No abstract available.

PMID:
8316313
16.

Agenesis of the right upper lobe.

Maesen FP, Geraedts WH, Goei R.

Chest. 1993 May;103(5):1612-4.

PMID:
8486058
17.

Formoterol suspension aerosol. Comparison with formoterol solution aerosol for 12 weeks in asthmatic patients.

Maesen FP, Nakratzas G, Bantje TA, Prins J, Zweers PG.

Chest. 1992 Nov;102(5):1544-9.

PMID:
1424880
18.

Formoterol as dry powder inhalation. A dose finding study in comparison with formoterol metered dose inhaler and placebo.

Maesen FP, Costongs R, Smeets SJ, Zweers PG, Goedhart DM.

Chest. 1992 May;101(5):1376-81.

PMID:
1582300
19.

Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.

Davies BI, Maesen FP, van den Bergh JJ, Costongs RJ, Geraedts WH, Gubbelmans HL, Meek JC.

Infection. 1992;20 Suppl 1:S22-5.

PMID:
1526671
20.
21.

Pain in scar as an early symptom of acquired thoracic lung hernia.

Meek JC, Bollen E, Koudstaal J, Versteege C, Maesen FP.

Eur Respir J. 1991 Apr;4(4):505-7.

PMID:
1855581
22.

Concentrations of cefixime in bronchial mucosa and sputum.

Maesen FP, Costongs R, Davies BI.

Thorax. 1990 Dec;45(12):982-3. No abstract available.

23.

Formoterol in the treatment of nocturnal asthma.

Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG.

Chest. 1990 Oct;98(4):866-70.

PMID:
1976487
24.

Cefaclor in the treatment of chronic bronchitis.

Maesen FP, Geraedts WH, Davies BI.

J Antimicrob Chemother. 1990 Sep;26(3):456-8. No abstract available.

PMID:
2228836
25.

Temafloxacin in acute purulent exacerbations of chronic bronchitis.

Davies BI, Maesen FP, Gubbelmans HL, Cremers HM.

J Antimicrob Chemother. 1990 Aug;26(2):237-46.

PMID:
2120178
26.

Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients.

Maesen FP, Davies BI, van den Bergh JJ, Gubbelmans HL, Meek JC, Geraedts WH.

J Antimicrob Chemother. 1990 Mar;25(3):413-22.

PMID:
2187013
27.

Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.

Maesen FP, Smeets JJ, Gubbelmans HL, Zweers PG.

Chest. 1990 Mar;97(3):590-4.

PMID:
1968371
28.

Treatment of Branhamella catarrhalis infections.

Davies BI, Maesen FP.

J Antimicrob Chemother. 1990 Jan;25(1):1-4. Review. No abstract available.

PMID:
2108111
29.

Long-term efficacy of formoterol compared to salbutamol.

Hekking PR, Maesen F, Greefhorst A, Prins J, Tan Y, Zweers P.

Lung. 1990;168 Suppl:76-82.

PMID:
1974686
30.
31.

Drug interactions with quinolones.

Davies BI, Maesen FP.

Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1083-90. Review.

PMID:
2570456
32.
33.
34.

Cefodizime in acute purulent exacerbations of chronic respiratory disease.

Maesen FP, Davies BI, Baur C, Sumajow CA.

J Antimicrob Chemother. 1988 Aug;22(2):229-35.

PMID:
3182418
35.

[A nasal form of pigeon breeder's disease; a new disease picture].

Maesen FP, Berrens L.

Ned Tijdschr Geneeskd. 1988 Jun 18;132(25):1168-70. Dutch. No abstract available.

PMID:
3398946
36.

A patient with methotrexate lung and granulomatous changes in the liver--or just sarcoidosis?

van Deursen CT, Koudstaal J, Maesen FP.

Int J Clin Pharmacol Ther Toxicol. 1988 Jun;26(6):293-6.

PMID:
3410605
37.

The epidemiology of respiratory tract pathogens in southern Netherlands.

Davies BI, Maesen FP.

Eur Respir J. 1988 May;1(5):415-20.

PMID:
3139445
38.

Respiratory infections: clinical experiences with the new quinolones.

Davies BI, Maesen FP.

Pharm Weekbl Sci. 1987 Dec 11;9 Suppl:S53-7.

PMID:
3438151
39.

Regression of a malignant tumour of the pleura.

Maesen F, Willighagen R.

Eur J Respir Dis. 1987 Aug;71(2):135-8. No abstract available.

PMID:
3622665
40.

Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.

Davies BI, Maesen FP, Teengs JP.

Infection. 1987 Jul-Aug;15(4):253-6.

PMID:
3312021
41.

Studies on a new formulation of ceftazidime--ceftazidime arginine--in patients with recurrent chest infections.

Davies BI, Maesen FP, Baur C, Evers WB.

J Antimicrob Chemother. 1987 Jul;20(1):133-6.

PMID:
3305461
42.

Clinical efficacy of the new quinolones in lower respiratory infections.

Davies BI, Maesen FP.

Chemioterapia. 1987 Jun;6(2 Suppl):447-8. No abstract available.

PMID:
3509469
43.

Ofloxacin and antacids.

Maesen FP, Davies BI, Geraedts WH, Sumajow CA.

J Antimicrob Chemother. 1987 Jun;19(6):848-50. No abstract available.

PMID:
3475268
44.

Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.

Maesen FP, Davies BI, Baur C.

J Antimicrob Chemother. 1987 Mar;19(3):373-83.

PMID:
3494724
45.

Penetration of ofloxacin from blood to sputum.

Davies BI, Maesen FP, Geraedts WH, Baur C.

Drugs. 1987;34 Suppl 1:26-32.

PMID:
3481324
46.

The use of quinolones in respiratory tract infections.

Maesen FP, Davies BI, Geraedts WH, Baur C.

Drugs. 1987;34 Suppl 1:74-9.

PMID:
3325259
47.

Ketotifen and methacholine-induced bronchospasm.

Tjwa MK, Smeets J, Maesen F.

Allergy. 1986 Nov;41(8):551-5.

PMID:
3544935
48.

Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease.

Maesen FP, Davies BI, Baur C, Sumajow CA.

J Antimicrob Chemother. 1986 Nov;18(5):629-34.

PMID:
3468098
49.

Doxycycline in respiratory infections: a re-assessment after 17 years.

Maesen FP, Davies BI, van Noord JA.

J Antimicrob Chemother. 1986 Oct;18(4):531-6.

PMID:
3771434
50.

Quinolones in chest infections.

Davies BI, Maesen FP.

J Antimicrob Chemother. 1986 Sep;18(3):296-9. Review. No abstract available.

PMID:
3533884

Supplemental Content

Loading ...
Support Center